Financial Counselors Inc’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,820
Closed -$229K 540
2020
Q4
$229K Buy
3,820
+220
+6% +$12.9K 0.01% 491
2020
Q3
$216K Sell
3,600
-320
-8% -$18.6K 0.01% 460
2020
Q2
$206K Sell
3,920
-3,160
-45% -$132K 0.01% 480
2020
Q1
$237K Buy
7,080
+2,160
+44% +$89.7K 0.01% 395
2019
Q4
$223K Buy
+4,920
New +$209K 0.01% 497

Other funds holding PCRX

Financial Counselors Inc's PCRX Position: Q1 2021 in Review

Financial Counselors Inc sold out of Pacira BioSciences (PCRX) in Q1 2021, closing a stake of 3,820 shares — an estimated $229K sold.

Financial Counselors Inc first reported a position in PCRX in Q4 2019 and held it in 5 quarters. The position peaked at $237K in Q1 2020. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2021.

  • Financial Counselors Inc reported no remaining Pacira BioSciences position as of Q1 2021 after selling out during the quarter.
  • Financial Counselors Inc sold 3,820 Pacira BioSciences shares in Q1 2021, an estimated $229K.
  • Financial Counselors Inc first reported a position in Pacira BioSciences in Q4 2019 and held it in 5 quarters.
  • Financial Counselors Inc's Pacira BioSciences position peaked at $237K in Q1 2020.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2021.

Based on Financial Counselors Inc's 13F filing for Q1 2021, filed 29 Apr 2021.